Key Metrics
5.4
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.87
5-Year SI
5-year SI
- N/A 2-year SI
- 0.89 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Medicine (miscellaneous)
SJR
- Q2 Medicine (miscellaneous)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.43
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
6 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Confidence interval
- Rheumatoid arthritis
- Odds ratio
- Clinical success
- Adrenalectomy
- Everolimus
- Disease activity
- High-resolution computed tomography
- Endothelial dysfunction
- Biceps
- Rotator cuff
- Type 2 diabetes
- Systematic review
- Oxidative stress
- Multiple sclerosis
- Oncology patients
- Primary care
- Proportion of days covered
- Methotrexate
- Corpus callosum
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 12 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 12 |
| Article Processing Charges | USD 2300 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Therapeutic Advances in Chronic Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Effect of short-term cardiac function changes after cardiac resynchronization therapy on long-term prognosis in heart failure patients with and without diabetes.
- 1 Jan 24
- Therapeutic advances in chronic disease
-
Full paper
Predictors of seizure outcomes in stereo-electroencephalography-guided radio-frequency thermocoagulation for MRI-negative epilepsy.
- 1 Jan 24
- Therapeutic advances in chronic disease
-
Full paper
Clinical and imaging findings in enteropathic spondyloarthritis with special emphasize in diagnostic delay: a cross-sectional study.
- 1 Jan 24
- Therapeutic advances in chronic disease
-
Full paper
Epidemiological characteristics, etiological spectrum, and outcomes of adult patients with pericardial effusion at a Teaching Hospital in Somalia.
- 1 Jan 24
- Therapeutic advances in chronic disease
-
Full paper
Real-world safety and effectiveness of secukinumab in adult patients with moderate to severe plaque psoriasis: results from postmarketing surveillance in Korea.
- 1 Jan 24
- Therapeutic advances in chronic disease
-
Full paper
Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiographic left ventricular hypertrophy, in end-stage kidney disease patients.
- 1 Jan 24
- Therapeutic advances in chronic disease
Scite analysis
Powered by scite_
682 articles received 10.1k citations see all
- 243 Supporting
- 9,483 Mentioning
- 29 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 4 Corrections
- 4 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
1%
4 to 6 months
54%
7 to 9 months
35%
Above 9 months
10%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Therapeutic Advances in Chronic Disease been actively publishing?
Therapeutic Advances in Chronic Disease has been in operation since 2010 till date.
What is the publishing frequency of Therapeutic Advances in Chronic Disease ?
Therapeutic Advances in Chronic Disease published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Chronic Disease publish last years ?
In 2023, Therapeutic Advances in Chronic Disease published 84 articles.
What is the eISSN & pISSN for Therapeutic Advances in Chronic Disease ?
For Therapeutic Advances in Chronic Disease,eISSN is 2040-6231 and pISSN is2040-6223.
What is Citescore for Therapeutic Advances in Chronic Disease ?
Citescore for Therapeutic Advances in Chronic Disease is 5.4.
What is SNIP score for Therapeutic Advances in Chronic Disease ?
SNIP score for Therapeutic Advances in Chronic Disease is 1.43.
What is the SJR for Therapeutic Advances in Chronic Disease ?
SJR for Therapeutic Advances in Chronic Disease is Q2.
Who is the publisher of Therapeutic Advances in Chronic Disease ?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Chronic Disease.